Literature DB >> 20179717

Are glucocorticoids a treatment or a risk factor?

Michiel Rienstra, Isabelle C Van Gelder.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20179717     DOI： 10.1038/nrcardio.2010.2

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Is inflammation a risk factor for recurrent atrial fibrillation?

Authors:  Marcelle D Smit; Isabelle C Van Gelder
Journal:  Europace       Date:  2008-12-10       Impact factor: 5.214

2.  Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis.

Authors:  Kwok M Ho; Jen Aik Tan
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

3.  Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.

Authors:  Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R Cummings; Roland D Chapurlat; Henrik Toft Sørensen
Journal:  Arch Intern Med       Date:  2009-10-12

4.  Corticosteroids and the risk of atrial fibrillation.

Authors:  Cornelis S van der Hooft; Jan Heeringa; Guy G Brusselle; Albert Hofman; Jacqueline C M Witteman; J Herre Kingma; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal:  Arch Intern Med       Date:  2006-05-08

5.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.

Authors:  P Bruins; H te Velthuis; A P Yazdanbakhsh; P G Jansen; F W van Hardevelt; E M de Beaumont; C R Wildevuur; L Eijsman; A Trouwborst; C E Hack
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

Review 7.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

8.  Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.

Authors:  John Dernellis; Maria Panaretou
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

Review 9.  New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.

Authors:  Bas A Schoonderwoerd; Marcelle D Smit; Lucas Pen; Isabelle C Van Gelder
Journal:  Europace       Date:  2008-05-13       Impact factor: 5.214
  9 in total
  1 in total

1.  Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.

Authors:  Mar Pujades-Rodriguez; Ann W Morgan; Richard M Cubbon; Jianhua Wu
Journal:  PLoS Med       Date:  2020-12-03       Impact factor: 11.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.